Feed Preview

Fast Growing

Alzheimer's Disease: RNA Regulation

Alzheimer's Disease: RNA Regulation diagram by Shelton et al, PLOS Genetics
Shelton et al, PLOS Genetics

RNA regulation involves several mechanisms that are used by cells to decreases or increase the production of RNA. Issues with RNA regulation are associated with Alzheimer's Disease (AD). Here are the latest discoveries pertaining to RNA regulation and this disease.

Top 20 most recent papers
Acta Neuropathologica

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Acta NeuropathologicaJanuary 20, 2020
Sven J van der LeeHenne Holstege
6
Journal of Alzheimer's Disease : JAD

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Sarah WestwoodSimon Lovestone
Neuron

Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts

NeuronJanuary 28, 2020
Mary Alice AllnuttSteven Jacobson
30
3
Scientific Reports

Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons

Scientific ReportsJanuary 19, 2020
Tugce Munise SatirPetra Bergström
2
1
1
Journal of Alzheimer's Disease : JAD

Sex-Specific Associations Between Depressive Symptoms and Risk for Subsequent Dementia

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Kathrin HeserMichael Wagner
bioRxiv

Herpes zoster in HIV-1 infection: the role of CSF pleocytosis in secondary CSF escape and discordance

bioRxivJanuary 28, 2020
Lars HagbergMagnus Gisslén
Diabetologia

PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes in mice

DiabetologiaJanuary 28, 2020
Yi-Chun ChenC Bruce Verchere
9
Journal of Alzheimer's Disease : JAD

Pine Bark Polyphenolic Extract Attenuates Amyloid-β and Tau Misfolding in a Model System of Alzheimer's Disease Neuropathology

Journal of Alzheimer's Disease : JADJanuary 21, 2020
Kenjiro OnoGiulio Maria Pasinetti
1
Journal of Alzheimer's Disease : JAD

Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Fúlvio R MendesSylvain Doré
Journal of Alzheimer's Disease : JAD

Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Miharu NakanishiHeii Arai
Journal of Alzheimer's Disease : JAD

Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Michael Malek-AhmadiElliott J Mufson
Journal of Alzheimer's Disease : JAD

Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Leonie BeyerAlzheimer’s Disease Neuroimaging Initiative
Journal of Alzheimer's Disease : JAD

Partial Mitigation of Oxidized Phospholipid-Mediated Mitochondrial Dysfunction in Neuronal Cells by Oxocarotenoids

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Opeyemi S AdemowoHelen R Griffiths
PloS One

Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease

PloS OneJanuary 25, 2020
Eun-Gyung LeeChang-En Yu
Journal of Alzheimer's Disease : JAD

Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Jianping JiaLuoyi Xu
Journal of Alzheimer's Disease : JAD

Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease1,2

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Ali Ezzati, Richard B Lipton
1
Scientific Reports

Theoretical analyses and experimental validation of the effects caused by the fluorinated substituent modification of DNA

Scientific ReportsJanuary 26, 2020
Jun KosekiHideshi Ishii
Journal of Alzheimer's Disease : JAD

Neuroticism-Withdrawal and Neuroticism-Volatility Differently Influence the Risk of Neuropsychiatric Symptoms in Alzheimer's Disease

Journal of Alzheimer's Disease : JADJanuary 28, 2020
Jean-Michel DoreyPierre Krolak-Salmon
Journal of Alzheimer's Disease : JAD

Resistance Exercise Decreases Amyloid Load and Modulates Inflammatory Responses in the APP/PS1 Mouse Model for Alzheimer's Disease

Journal of Alzheimer's Disease : JADJanuary 21, 2020
Debora HashiguchiBeatriz Monteiro Longo
1
Biochemical and Biophysical Research Communications

Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrins

Biochemical and Biophysical Research CommunicationsJanuary 26, 2020
Sefan AsamitsuNorifumi Shioda
5

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-rna-regulation/cf295a8b-d130-4ba5-9e4e-222d91a713df